I would have thought they would release the announcement about the FDA meetings prior to the presentation on the 05/06/2018. Don't they have an obligation to us share holders if it is considered price sensitive prior to announcing at a public presentation???
We know on 15th May they said next announcement would be within 30 days, so unless the next announcement relating to the FDA meeting is considered none price sensitive they would need to formally advise share holders prior to the presentation on the 5th June 2018.
Just my thoughts, but am I wrong?
Baldy
RCE Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)